Global Fragment Based Drug Discovery Market wird von Komponenten (Biophysikalische Techniken (NMR-Spektroskopie, Differential Scanning Fluorimetry (DS....
Zu den wichtigsten Akteuren im globalen Fragment Based Drug Discovery Market gehören Emerald BioStructures, Inc., Crown Bioscience, Vernalis Research, Sygnature Discovery, Shanghai ChemPartner, SARomics Biostructures, Red Glead Discovery, Domainex, CRELUX, ComInnex, Creative Biolabs, ChemAxon, 2bind, Amgen und University of California, San Francisco.
Global Fragment Based Drug Discovery Market